Compare DNTH & MDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNTH | MDA |
|---|---|---|
| Founded | 2015 | 1969 |
| Country | United States | Canada |
| Employees | N/A | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.2B |
| IPO Year | 2018 | 2026 |
| Metric | DNTH | MDA |
|---|---|---|
| Price | $88.63 | $31.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $121.00 | $37.50 |
| AVG Volume (30 Days) | 523.2K | ★ 599.8K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,036,000.00 | N/A |
| Revenue This Year | N/A | $12.11 |
| Revenue Next Year | $29.48 | $11.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.77 | $23.23 |
| 52 Week High | $96.50 | $37.45 |
| Indicator | DNTH | MDA |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 47.91 |
| Support Level | $33.94 | $28.96 |
| Resistance Level | $96.50 | $33.75 |
| Average True Range (ATR) | 4.02 | 1.66 |
| MACD | -1.21 | -0.32 |
| Stochastic Oscillator | 45.82 | 25.49 |
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.